Great Point Partners as of Dec. 31, 2018
Portfolio Holdings for Great Point Partners
Great Point Partners holds 39 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| BioCryst Pharmaceuticals (BCRX) | 7.8 | $62M | 7.6M | 8.07 | |
| Iovance Biotherapeutics (IOVA) | 6.2 | $49M | 5.6M | 8.85 | |
| Global Blood Therapeutics In | 6.1 | $48M | 1.2M | 41.05 | |
| Acceleron Pharma | 5.7 | $45M | 1.0M | 43.55 | |
| ACADIA Pharmaceuticals (ACAD) | 5.6 | $45M | 2.8M | 16.17 | |
| Ptc Therapeutics I (PTCT) | 5.3 | $42M | 1.2M | 34.32 | |
| Kura Oncology (KURA) | 4.9 | $39M | 2.8M | 14.04 | |
| United Therapeutics Corporation (UTHR) | 4.8 | $38M | 351k | 108.90 | |
| Zogenix | 4.6 | $37M | 1.0M | 36.46 | |
| Audentes Therapeutics | 4.5 | $35M | 1.7M | 21.32 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.2 | $33M | 200k | 165.71 | |
| Puma Biotechnology (PBYI) | 3.5 | $28M | 1.4M | 20.35 | |
| Array BioPharma | 3.3 | $26M | 1.9M | 14.25 | |
| Spark Therapeutics | 3.1 | $25M | 631k | 39.14 | |
| Five Prime Therapeutics | 2.8 | $22M | 2.4M | 9.30 | |
| Intercept Pharmaceuticals In | 2.5 | $20M | 200k | 100.79 | |
| Cytokinetics (CYTK) | 2.5 | $20M | 3.2M | 6.32 | |
| Zafgen | 2.2 | $18M | 3.6M | 4.95 | |
| Foamix Pharmaceuticals | 1.8 | $15M | 4.0M | 3.59 | |
| Savara (SVRA) | 1.7 | $14M | 1.8M | 7.57 | |
| Tg Therapeutics (TGTX) | 1.6 | $12M | 3.0M | 4.10 | |
| Osmotica Pharmaceuticals (RVLPQ) | 1.5 | $12M | 1.5M | 7.75 | |
| Cymabay Therapeutics | 1.4 | $11M | 1.4M | 7.87 | |
| Krystal Biotech (KRYS) | 1.3 | $10M | 492k | 20.78 | |
| Millendo Therapeutics | 1.3 | $10M | 1.3M | 7.95 | |
| AMAG Pharmaceuticals | 1.3 | $10M | 665k | 15.19 | |
| Enanta Pharmaceuticals (ENTA) | 1.3 | $10M | 144k | 70.83 | |
| Proteostasis Therapeutics In | 1.2 | $9.9M | 3.0M | 3.24 | |
| Menlo Therapeutics | 1.1 | $9.1M | 2.2M | 4.12 | |
| Novavax | 1.1 | $8.3M | 4.5M | 1.84 | |
| Protagonist Therapeutics (PTGX) | 0.8 | $6.4M | 956k | 6.73 | |
| Sage Therapeutics (SAGE) | 0.6 | $5.0M | 52k | 95.81 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $4.6M | 400k | 11.39 | |
| Voyager Therapeutics (VYGR) | 0.4 | $3.4M | 365k | 9.40 | |
| Madrigal Pharmaceuticals (MDGL) | 0.4 | $3.1M | 28k | 112.73 | |
| Alnylam Pharmaceuticals (ALNY) | 0.4 | $2.9M | 40k | 72.92 | |
| Argenx Se (ARGX) | 0.2 | $1.8M | 19k | 96.05 | |
| Sunesis Pharmaceuticals Inc Ne | 0.0 | $134k | 318k | 0.42 | |
| Streamline Health Solutions (STRM) | 0.0 | $105k | 130k | 0.81 |
